Skip to main content
$1.57 +0.06 (+3.97%)
Market Cap
$13.73M
Shares
9.09M

Price & Indicators

20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$1.51 Open$1.48 Day$1.46–1.53 52W$0.71–1.73 Avg vol 30d70K Short int36K · 0.4% float · 1.0d Short vol80% DataNov 2025–Jul 2026 Filing10-Q · May 12

Up next

FQ3-26 quarter ends
~Sep 30, 2026 Est
filed May 12, 2026

Equibles Rating

blended score · not investment advice
Overall
Buy
SellHoldBuy
Technical Buy Momentum Very Strong Sentiment Neutral Fundamentals Excellent Quant / Vol Very High
Market backdrop VIX 18.2 · elevated Equity put/call 0.71
Technical
price trend
Buy
50 / 200-day cross No cross
Price vs 50-day avg +24%
above
RSI (14) 63
neutral
MACD trend Positive
52-week position 78%
mid-range
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Very Strong
1-month return +25%
trailing
6-month return +66%
trailing
YTD return +76%
this year
Relative strength +58%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50/200-day averages unavailable
Institutional flow Flat
0% holders QoQ · +4 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
0.40% of float · ▼ -48.5% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
6 holders — 13F breadth
Squeeze score 42
elevated · 0–100
Fundamentals
Excellent
Gross margin 56%
Balance sheet $2.1M
net cash
Quant / Vol
risk profile
Very High
Volatility 129%
annualized · 1-yr
Max drawdown −51%
past year
ATR 9.0%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Buy
0 · 4 · 2
50 / 200-day cross
No cross Neutral
Price vs 50-day avg
+24% Bullish
RSI (14)
63 Neutral
MACD trend
Positive Bullish
52-week position
78% Neutral
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Bullish · 1 of 6
Trend (MA cross) No cross
50/200-day averages unavailable
Institutional flow Flat
0% holders QoQ · +4 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
0.40% of float · ▼ -48.5% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
6 holders — 13F breadth
Price context
position in its 52-week range
52-wk low $1 Now $2 · 78% 52-wk high $2
vs 50-day avg +24%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Drug Manufacturers - Specialty & Generic — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
CABR
Caring Brands, Inc.
this stock
$13.73M +76.0% 0.4%
TAK
Takeda Pharmaceutical Co Ltd
$55.95B +12.4% 0.1%
GALDY
Galderma Group AG/ADR
$50.49B +4.5% 0.0%
HLN
Haleon plc
$45.23B +1.6% 0.3%
JHPCY
Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR
$45.13B 0.0%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
6
% held
2.3%
Net QoQ
+102.3K sh
Top holder
WELLS FARGO & COMPANY/MN
Held Float
View
Held by Funds
Fund positions
3
View
Short & Settlement
Short Interest Falling
Shares short
36.5K
Days to cover
1.0d
Change
-34.4K sh
View
Short Volume
Short vol %
80%
As of
Jul 29, 2026
Short Total
View
Fails to Deliver
FTD shares
4.7K
Value
$5.4K
As of
Jun 26, 2026
View
Off-Exchange
Off-exchange %
60.3%
Week of
May 4, 2026
Off-exch Lit
View
Financials
Financials
Revenue (FY)
$4.2K
Net income (FY)
$-6.3M
EPS diluted
$-0.46
View
Filings
SEC Filings
Latest
8-K
Filed
Jul 17, 2026
This year
14
View
Exempt Offerings
Offering
$3.0M
Filed
Apr 23, 2024
View

Performance

5D 20D 120D MTD YTD
CABR +10.6% +24.8% +65.9% +21.8% +76.0%
SPY -1.0% 0.0% +7.4% -0.8% +8.6%
vs SPY +11.6% +24.8% +58.5% +22.6% +67.4%
Key facts CIK 2020737 CUSIP 14216J109 Visit website Investor relations